ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 215 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $22,579,000 | -30.0% | 558,607 | -0.3% | 0.01% | -22.2% |
| Q2 2015 | $32,242,000 | -34.3% | 560,228 | -27.3% | 0.01% | -30.8% |
| Q1 2015 | $49,040,000 | +11.2% | 770,229 | +7.8% | 0.01% | +8.3% |
| Q4 2014 | $44,110,000 | +56.3% | 714,450 | -1.7% | 0.01% | +50.0% |
| Q3 2014 | $28,217,000 | -43.8% | 726,675 | -50.2% | 0.01% | +14.3% |
| Q2 2014 | $50,250,000 | +72.6% | 1,458,666 | +116.5% | 0.01% | -12.5% |
| Q1 2014 | $29,111,000 | +12.0% | 673,705 | +3.2% | 0.01% | +14.3% |
| Q4 2013 | $26,002,000 | -47.0% | 652,662 | -50.0% | 0.01% | 0.0% |
| Q3 2013 | $49,038,000 | +178.8% | 1,306,330 | +99.5% | 0.01% | +16.7% |
| Q2 2013 | $17,591,000 | – | 654,705 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |